15:10:55United States

Oramed Pharmaceuticals Inc. (ORMP)

NASDAQ

Key stats Fiscal year 2025

Income statement

Revenue
2,000,000
Net income
75,324
Gross profit
13,000
Operating income
-15,088,000
Earnings per share
1.50
Net margin
3.77

Balance sheet

Total assets
230,864,000
Shareholders' equity
199,744,000
Cash and equivalents
45,947,000
Current ratio
6.98

Cash flow and ratios

Operating cash flow
-9,145,000
Free cash flow
-9,154,000
Return on equity
0.04

Revenue and net income

Fiscal year end: · Source: SEC EDGAR

Oramed Pharmaceuticals Inc. trades on NASDAQ under the ticker symbol ORMP. This page brings together its price chart, company profile, key financial figures and technical indicators.

Company profile

Technical analysis